Convergence Investment Partners’s Medifast MED Stock Holding History

Convergence Investment Partners’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,163	Closed	-$1.46M	–	253
2021 Q2	$1.46M	Buy	5,163 +4,207	+440%	+$1.14M	0.63%	61
2021 Q1	$202K	Sell	956 -322	-25%	-$77.1K	0.09%	203
2020 Q4	$251K	Buy	+1,278	New	+$226K	0.13%	149
2019 Q3	–	Sell	-820	Closed	-$105K	–	334
2019 Q2	$105K	Buy	+820	New	+$114K	0.03%	294
2018 Q4	–	Sell	-1,553	Closed	-$344K	–	344
2018 Q3	$344K	Sell	1,553 -1,634	-51%	-$331K	0.07%	259
2018 Q2	$510K	Sell	3,187 -3,799	-54%	-$486K	0.07%	258
2018 Q1	$653K	Sell	6,986 -95	-1%	-$7.1K	0.09%	252
2017 Q4	$494K	Buy	+7,081	New	+$470K	0.07%	269
2017 Q1	–	Sell	-30,121	Closed	-$1.25M	–	361
2016 Q4	$1.25M	Sell	30,121 -2,727	-8%	-$110K	0.17%	233
2016 Q3	$1.24M	Buy	+32,848	New	+$1.18M	0.18%	215

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Convergence Investment Partners's MED Position: Q3 2021 in Review

Convergence Investment Partners sold out of Medifast (MED) in Q3 2021, closing a stake of 5,163 shares — an estimated $1.46M sold.

Convergence Investment Partners first reported a position in MED in Q3 2016 and held it in 10 quarters. The position peaked at $1.46M in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

Convergence Investment Partners reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
Convergence Investment Partners sold 5,163 Medifast shares in Q3 2021, an estimated $1.46M.
Convergence Investment Partners first reported a position in Medifast in Q3 2016 and held it in 10 quarters.
Convergence Investment Partners's Medifast position peaked at $1.46M in Q2 2021.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Convergence Investment Partners's 13F filing for Q3 2021, filed 25 Oct 2021.